Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Merola

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
The British Journal of Dermatology|February 3, 2015
Mosaic focal dermal hypoplasia caused by a novel somatic mutation in PORCN detected in affected skinJ Sheu, S J Divito, E P Hoffman, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 24, 2021
Hidradenitis suppurativa and sleep disorders: a population-based studyJ M Cohen, K Kridin, L M Perez-Chada, et al.
The British Journal of Dermatology|July 2, 2017
Lack of response to intravenous sodium thiosulfate in three cases of extensive connective tissue disease-associated calcinosis cutisP Song, N M Fett, J Lin, et al.
The British Journal of Dermatology|January 30, 2019
Plasma levels of tumour necrosis factor-α and adiponectin can differentiate patients with psoriatic arthritis from those with psoriasisC M Johnson, K Fitch, J F Merola, et al.
Lupus|March 11, 2014
Clinical manifestations and survival among adults with (SLE) according to age at diagnosisJ F Merola, B Bermas, B Lu, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 15, 2022
Effects of risankizumab on nail psoriasis in patients with active psoriatic arthritis: results from KEEPsAKE 1L E Kristensen, A M Soliman, K Papp, et al.
The British Journal of Dermatology|November 26, 2013
Diagnosing and treating psoriatic arthritis: an updateW H Boehncke, A Qureshi, J F Merola, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 11, 2020
Ixekizumab improves secondary lesional signs, pain and sexual health in patients with moderate-to-severe genital psoriasisJ F Merola, P-D Ghislain, J N Dauendorffer, et al.
Lupus Science & Medicine|April 11, 2015
Redefining cutaneous lupus erythematosus: a proposed international consensus approach and results of a preliminary questionnaireJ F Merola, F Nyberg, F Furukawa, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 23, 2021
Ixekizumab provides persistent improvements in health-related quality of life and the sexual impact associated with moderate-to-severe genital psoriasis in adult patients during a 52-week, randomised, placebo-controlled, phase 3 clinical trialC Ryan, L Guenther, P Foley, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
The British Journal of Dermatology|February 3, 2015
Mosaic focal dermal hypoplasia caused by a novel somatic mutation in PORCN detected in affected skinJ Sheu, S J Divito, E P Hoffman, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 24, 2021
Hidradenitis suppurativa and sleep disorders: a population-based studyJ M Cohen, K Kridin, L M Perez-Chada, et al.
The British Journal of Dermatology|July 2, 2017
Lack of response to intravenous sodium thiosulfate in three cases of extensive connective tissue disease-associated calcinosis cutisP Song, N M Fett, J Lin, et al.
The British Journal of Dermatology|January 30, 2019
Plasma levels of tumour necrosis factor-α and adiponectin can differentiate patients with psoriatic arthritis from those with psoriasisC M Johnson, K Fitch, J F Merola, et al.
Lupus|March 11, 2014
Clinical manifestations and survival among adults with (SLE) according to age at diagnosisJ F Merola, B Bermas, B Lu, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 15, 2022
Effects of risankizumab on nail psoriasis in patients with active psoriatic arthritis: results from KEEPsAKE 1L E Kristensen, A M Soliman, K Papp, et al.
The British Journal of Dermatology|November 26, 2013
Diagnosing and treating psoriatic arthritis: an updateW H Boehncke, A Qureshi, J F Merola, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 11, 2020
Ixekizumab improves secondary lesional signs, pain and sexual health in patients with moderate-to-severe genital psoriasisJ F Merola, P-D Ghislain, J N Dauendorffer, et al.
Lupus Science & Medicine|April 11, 2015
Redefining cutaneous lupus erythematosus: a proposed international consensus approach and results of a preliminary questionnaireJ F Merola, F Nyberg, F Furukawa, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 23, 2021
Ixekizumab provides persistent improvements in health-related quality of life and the sexual impact associated with moderate-to-severe genital psoriasis in adult patients during a 52-week, randomised, placebo-controlled, phase 3 clinical trialC Ryan, L Guenther, P Foley, et al.
Pageof 4